Literature DB >> 20955735

Essential roles of SIRPα in homeostatic regulation of skin dendritic cells.

Hiroko Iwamura1, Yasuyuki Saito, Miho Sato-Hashimoto, Hiroshi Ohnishi, Yoji Murata, Hideki Okazawa, Yoshitake Kanazawa, Tetsuya Kaneko, Shinya Kusakari, Takenori Kotani, Yoshihisa Nojima, Takashi Matozaki.   

Abstract

Signal regulatory protein α (SIRPα) is an immunoglobulin superfamily protein that is predominantly expressed in dendritic cells (DCs). Its cytoplasmic region binds SHP-1 or SHP-2 protein tyrosine phosphatases, while its extracellular region interacts with CD47, another immunoglobulin superfamily protein, constituting cell-cell signaling. SIRPα was previously shown to be important for development of contact hypersensitivity, likely as a result of its positive regulation of the priming by DCs of CD4(+) T cells. However, the mechanism by which SIRPα regulates DC functions remains unknown. Here we found that the number of I-A(+) cells, which represent migratory DCs such as Langerhans cells (LCs) or dermal DCs from the skin, in the peripheral lymph nodes (LNs) was markedly decreased in mice expressing a mutant form of SIRPα that lacks the cytoplasmic region compared with that of wild-type (WT) mice. In addition, an increase of fluorescein isothiocyanate (FITC)-bearing I-A(+) cells in the draining lymph nodes (LNs) after skin-painting with FITC was markedly blunted in SIRPα mutant mice. However, migratory ability, as well as expression of CCR7, of bone marrow-derived DCs prepared from SIRPα mutant mice were not impaired. By contrast, the number of I-A(+) LCs in the epidermis of SIRPα mutant mice was markedly decreased compared with that of WT mice. In addition, the mRNA expression of transforming growth factor-β receptor II in LCs of SIRPα mutant mice was markedly decreased compared with that of WT mice. These results suggest that SIRPα is important for homeostasis of LCs in the skin, as well as of migratory DCs in the LNs, but unlikely for migration of these cells from the skin to draining LNs. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955735     DOI: 10.1016/j.imlet.2010.10.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

Review 1.  TGF-β1-induced transcription factor networks in Langerhans cell development and maintenance.

Authors:  X Zhang; J Gu; F-S Yu; L Zhou; Q-S Mi
Journal:  Allergy       Date:  2016-04-15       Impact factor: 13.146

2.  Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells.

Authors:  Boyang Ren; Huan Xia; Yijun Liao; Hang Zhou; Zhongnan Wang; Yaoyao Shi; Mingzhao Zhu
Journal:  Elife       Date:  2022-05-05       Impact factor: 8.713

3.  Signal regulatory protein alpha (SIRPα) regulates the homeostasis of CD103(+) CD11b(+) DCs in the intestinal lamina propria.

Authors:  Charlotte L Scott; Zangerle Murray Tfp; Katherine S H Beckham; Gillian Douce; Allan McI Mowat
Journal:  Eur J Immunol       Date:  2014-10-27       Impact factor: 5.532

4.  CD47 antibody blockade suppresses microglia-dependent phagocytosis and monocyte transition to macrophages, impairing recovery in EAE.

Authors:  Huan Wang; Gail Newton; Liguo Wu; Lih-Ling Lin; Amy S Miracco; Sridaran Natesan; Francis W Luscinskas
Journal:  JCI Insight       Date:  2021-11-08

5.  SIRPα - CD47 axis regulates dendritic cell-T cell interactions and TCR activation during T cell priming in spleen.

Authors:  Anu Autio; Huan Wang; Francisco Velázquez; Gail Newton; Charles A Parkos; Pablo Engel; Daniel Engelbertsen; Andrew H Lichtman; Francis W Luscinskas
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

Review 6.  The Critical Importance of Spatial and Temporal Scales in Designing and Interpreting Immune Cell Migration Assays.

Authors:  Jennifer Frattolin; Daniel J Watson; Willy V Bonneuil; Matthew J Russell; Francesca Fasanella Masci; Mikaila Bandara; Bindi S Brook; Robert J B Nibbs; James E Moore
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.